Ravidasvir is under investigation in clinical trial NCT02961426 (Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection).
联合利托那韦强化的达诺瑞韦钠片和利巴韦林,用于治疗初治的基因1b型慢性丙型肝炎病毒感染的非肝硬化成人患者,不得作为单药治疗。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.